Immunotherapy in its various forms has permanently changed the landscape of clinical oncology; antigen receptor (CAR) T cells are one of the most significant adoptive cell therapies to have helped usher in this era. However, the assays currently used to optimize CAR do not necessarily correlate with cancer-killing efficacy, and often require excessive labor or are restricted to providing only end-point data.
Download this application note to discover an assay solution for studying and optimizing CAR T-cells that can:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy